| Ticker | XERS |
|---|---|
| ISIN | US98422E1038 |
| Sector | Tecnología |
| Mercado | NASDAQ |
Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hy...
El precio actual de Xeris Biopharma Holdings, Inc (XERS) es de 6,06 , con una variación del 0,08%.
Xeris Biopharma Holdings, Inc opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones